Advanced search×

Prescription drug spending trends in the United States: looking beyond the turning point.

Murray M Aitken, Ernst R ER Berndt, and David M DM Cutler

Health Aff (Millwood) 28(1):w151-60 (2009) PMID 19088102

Annual growth in real prescription drug spending averaged 9.9 percent during 1997-2007 but has slowed since 2003, falling to 1.6 percent in 2007. More patent expirations, increased generic penetration, and reduced new product innovations have contributed to this turning point. We document trends and identify underlying components: declines in the role of blockbuster drugs, increased importance of biologics and vaccines relative to traditional pharmaceuticals, and a changing medication mix away from those prescribed principally by primary care physicians toward those mostly prescribed by specialists. We conclude with policy implications.

DOI: 10.1377/hlthaff.28.1.w151
Version: za2963e q8za1 q8zb5 q8zcb q8zd6 q8ze0 q8zf1 q8zgd

Similar articles you may find interesting…

  1. Achieving a high-performance health care system with universal access: what the United States can learn from other countries.
    Public Policy Committee of the American College of Physicians, Jack A Ginsburg, ... Joseph W Stubbs

    Ann Intern Med 148(1):55-75 (2008) PMID 18056654

    We can learn much from other health systems, the College recognizes that our political and social culture, demographics, and form of government will shape any solution for the United States. This caution notwithstanding, we have identified several approaches that have worked well for countries like...
  2. Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery.
    Martin Majlund Mikkelsen, Niels Holmark Andersen, ... Søren Paaske Johnsen

    Interact Cardiovasc Thorac Surg 9(3):484-90 (2009) PMID 19549646

    PDF not found
  3. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
    Thomas Decker TD Christensen

    Dan Med Bull 58(5):B4284 (2011) PMID 21535992

    We found that the clotting activity of coagulation factors II, VII, IX, and X and CAT exhibited no variability over a 6-week period. The activity of the coagulation factors and CAT was significantly associated with the INR, so these two tests can be used concomitantly and/or interchangeably with the...